Medtronic, Inc. company logo

# 1st Gen Model Medtronic, Inc. Electromedical equipment

Subscribe >> Deal exit on
Oct. 23, 2017
Deal entry on
Oct. 23, 2017
0.15%Expected margin
75.44% successful of 57 deals
$79.02 Last close price
at 23-oct-2017

MDT

Model's trade recommendations 0.30% Return for period

1.10% Annual return

$106.12B Market Cap

β 1.01  

MDT

Model (following trade recommendations)

MDT

Underlying stock

S&P 500

Index
Return for period 0.30%
0.83%
1.78%
52wk return -4.07%
-5.14%
16.82%
52wk Range
70.61—89.30
2000.54—2399.63
Sortino ratio 0.17
Sharpe ratio 0.14
Norm. RMSE 0.40%
Downside risk 6.14%
Volatility 7.45%
  • 1.84 (2.35%) Div (Yield)
  • BUY Analysts consensus recommendation

Medtronic is the world's leading medical technology company, pioneeringdevice-based therapies that restore health, extend life and alleviate pain.Primary products include those for bradycardia pacing, tachyarrhythmiamanagement, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries. The company's product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.

Industry sector: Medical

Sector classification: Electromedical equipment

Deep Learning based analysis and prediction model for Medtronic, Inc. (MDT) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for MDT model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 1350M
P/E 16.70
Shares Outstanding 1355M
% Held by Insiders 0.31%
% Held by Institutions 80.75%
EPS (last reported FY) $4.60
EPS (last reported Q) $1.12
EPS, estimated (last reported Q) $1.08
Total revenues $30 B
Net income $4 B